JAK Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA) and an Inadequate Response or Intolerance to TNF Inhibitors (TNFi-IR)

  • Sponsored by AbbVie Medical Affairs
 Jul 01, 2022 9:00 am

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2023 All Rights Reserved.

×